Medicus Pharma (MDCXW) Return on Capital Employed (2025)

Medicus Pharma (MDCXW) reported Return on Capital Employed of 23242.91% for Q4 2025, down 370.68% quarter-over-quarter from 4938.19% in Q3 2025.

Medicus Pharma (MDCXW) Return on Capital Employed (2025) Analysis & Trends

Medicus Pharma has reported Return on Capital Employed for 1 years, with the latest figure at 23242.91% in Q4 2025.

For the quarter ending Q4 2025, Return on Capital Employed changed N/A year-over-year to 23242.91%; the trailing twelve-month figure through Dec 2025 stood at 23242.91% (changed N/A YoY), and the FY2025 full-year result was 1648.77%, up 241263.0% from the prior year.
Return on Capital Employed for Q4 2025 stood at 23242.91%, down from 4938.19% in the prior quarter.
The five-year high for Return on Capital Employed was 630.27% in Q1 2025, with the low at 23242.91% in Q4 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROCE (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn	9.49%
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn	42.94%
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn	28.18%
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn	16.47%
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn	-5.22%
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn	15.87%
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn	21.53%
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn	-10.20%
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn	-6.84%
10	Medicus Pharma	-	-	-	-23,242.91%

Download Data